35441-11-3 Usage
Uses
Used in Chemical Synthesis:
2,6-Dihydroxynicotinamide is used as an intermediate in the chemical synthesis of various compounds. Its unique structure allows it to be a valuable building block for the creation of new molecules with specific properties and applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,6-dihydroxynicotinamide may be used as a precursor for the development of new drugs. Its chemical properties can be exploited to design and synthesize novel therapeutic agents with potential applications in treating various diseases and medical conditions.
Used in Research and Development:
2,6-Dihydroxynicotinamide is also used in research and development settings, where it can be employed to study the properties and behavior of nicotinamide derivatives. This can lead to a better understanding of their potential applications and the development of new technologies and products based on these findings.
Check Digit Verification of cas no
The CAS Registry Mumber 35441-11-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,4,4 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 35441-11:
(7*3)+(6*5)+(5*4)+(4*4)+(3*1)+(2*1)+(1*1)=93
93 % 10 = 3
So 35441-11-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N2O3/c7-5(10)3-1-2-4(9)8-6(3)11/h1-2H,(H2,7,10)(H2,8,9,11)
35441-11-3Relevant academic research and scientific papers
BORON-CONTAINING SMALL MOLECULES
-
Page/Page column 157, (2011/08/21)
Compounds, pharmaceutical formulations, and methods of treating anti-inflammatory conditions and/or helminth-associated diseases are disclosed.
NOVEL RING TRANSFORMATION REACTIONS AND THEIR APPLICATIONS TO THE SYNTHESES OF POTENTIAL ANTICANCER HETEROCYCLIC COMPOUNDS
Watanabe, K. A.,Su, T.-L.,Pankiewicz, K. W.,Harada, K.
, p. 289 - 307 (2007/10/02)
Novel heterocyclic ring trasformation reactions developed recently in our laboratory are described.They include pyrimidine to pyrimidine, pyrimidine to pyridine transformations.Also discussed are novel one-step procedures for conversion of 1,3-dimethyluracil derivatives into the pyridopyrimidine system.Some applications of these novel reactions to the syntheses of compounds of biological interest are also described.
